Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma.

We developed nomograms that could more objectively and reliably predict the individual survival of patients with OCCC compared with the FIGO staging system. These tools might assist in clinical decision-making and management of patients with OCCC to improve their survival outcomes.